EUVIMEDEUVIMED entdecken
Multizentrische Studie

Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processes

Angie Price, Hannah Simmons, Emily Gehring, Lauren Davis, Gwyneth Fischer, Ann R Klipsch, Erin Richmond, Janice E Sullivan, Steven J Steiner

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107701 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Angie Price und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Clinical Trials for Children, Rockville, MD, United States of America. Hauptthemen laut MEDLINE: Drug Industry, Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Significant barriers to advancing pediatric drug development continue despite federal incentives to expedite pediatric drug development. There is an urgent need to improve how clinical trials are designed, implemented, and conducted to increase the number of approved therapeutic interventions for children. METHODS: The Pediatric Improvement Collaborative for Clinical Trials & Research was created to measure timelines and address delays in the pediatric clinical trials process. This multi-site collaborative prospectively monitored sixteen time points in industry-sponsored pediatric clinical drug trials, including times to budget approval, contract execution, ancillary protocol review, Institutional Review Board approval, Site Initiation Visit, and first patient consented. RESULTS: Twenty-four sites contributed data on 330 industry-sponsored pediatric drug studies. The average duration to final study budget approval was 121 (range 3-585) days, to final study Institutional Review Board (IRB) approval was 51 (range 1-205) days, to Site Initiation Visit was 204 (range 23-600) days, and to first patient consented was 239 (range 30-534) days. CONCLUSION: Significant study start-up delays were noted in industry-sponsored clinical drug trials among a large group of pediatric sites. Delays and wide variation in all steps of the study process indicate multiple opportunities for improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug IndustryClinical Trials as TopicHumansChildTime FactorsUnited StatesEthics Committees, ResearchDrug DevelopmentPediatricsPatient SelectionProspective Studies

Stichwörter der Autor:innen

Clinical trialsMetricsNetworksPediatrics

Autor:innen und Institutionen

  • Institute for Advanced Clinical Trials for Children, Rockville, MD, United States of America.
  • Spark Excellence, LLC, St. Paul, MN, United States of America.
  • James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.
  • Le Bonheur Children's Hospital, Memphis, TN, United States of America.
  • University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States of America.
  • Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, United States of America.

Zitieren

APA

Price, A., Simmons, H., Gehring, E., Davis, L., Fischer, G., Klipsch, A. R., Richmond, E., Sullivan, J. E., & Steiner, S. J. (2024). Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processes. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107701

Vancouver

Price A, Simmons H, Gehring E, Davis L, Fischer G, Klipsch AR, et al. Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processes. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107701

BibTeX
@article{Price2024,
  author = {Price, Angie and Simmons, Hannah and Gehring, Emily and Davis, Lauren and Fischer, Gwyneth and Klipsch, Ann R and Richmond, Erin and Sullivan, Janice E and Steiner, Steven J},
  title = {Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processes},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107701}
}
Kostenlos starten →